Zodiac-JRD-MKJ Rights Issue Opens November 19 at ₹25
Key highlights
- Zodiac-JRD-MKJ will offer up to 1.60 crore fully paid-up shares at ₹25 each, raising up to ₹40 crore.
- Eligible shareholders receive rights entitlements in the ratio of 145 shares for every 100 shares held on November 11, 2026.
- The rights issue subscription period runs from November 19 to December 3, 2026.
- Rights entitlements can be traded on-market until November 30, 2026.
powered by IRIS

Zodiac-JRD-MKJ Ltd will open a ₹40 crore rights issue on November 19, 2026, offering up to 1.60 crore fully paid-up equity shares at ₹25 each to eligible shareholders in the ratio of 145 shares for every 100 shares held on November 11.
Know Zodiac-JRD-MKJ inside out
Results, valuation, peers and who's buying, in one view.
What are the terms of Zodiac-JRD-MKJ's rights issue?
Zodiac-JRD-MKJ has set the issue price at ₹25 per equity share, comprising a face value of ₹10 and a premium of ₹15 per share. The company plans to issue up to 1,60,00,000 fully paid-up equity shares, aggregating up to ₹40 crore.
The entitlement ratio is 145 new equity shares for every 100 equity shares held by an eligible shareholder on the record date. The issue is fully payable on application. The record date and ex-date for the corporate action were both November 11, 2026.
The offering is listed on the BSE. Zodiac-JRD-MKJ's equity shares are identified by BSE code 512587, while the rights entitlements have been assigned ISIN INE077B20026.
When can shareholders apply or trade rights entitlements?
Eligible shareholders can apply for Zodiac-JRD-MKJ shares under the rights issue between November 19 and December 3, 2026. Rights entitlements are scheduled to be credited to eligible shareholders' demat accounts on November 12, before the subscription window opens.
The rights entitlements can be traded or renounced on the stock exchange from November 19 until November 30. Shareholders can also renounce entitlements in full or in part through the permitted on-market or off-market process. Entitlements that are not used to apply for shares by the issue closing date will lapse.
The company has stated that applications can be made through online ASBA, or through physical ASBA where a shareholder's bank does not support the online facility. Holding rights entitlements alone does not result in the allotment of shares, as an application and payment of the issue price are required.
How did the Zodiac-JRD-MKJ rights issue receive approval?
Zodiac-JRD-MKJ's board originally authorised a rights issue of up to ₹40 crore on August 6, 2026, subject to required approvals. The board delegated authority to a Rights Issue Committee to settle the detailed terms and related matters.
BSE gave in-principle approval for the issue on November 3, 2026. The board then approved the final issue terms on November 4, including the ₹25 price, 145:100 entitlement ratio, and November 11 record date. The company's Letter of Offer is dated November 6, 2026.
The approvals were made under the applicable provisions of the Companies Act, 2013 and the Securities and Exchange Board of India (Issue of Capital and Disclosure Requirements) Regulations, 2018, as cited in the company's disclosures.
Got a follow-up? Ask IRIS
What is the expected allotment and listing schedule?
Zodiac-JRD-MKJ expects to finalise the basis of allotment on December 4, 2026, the day after the subscription window closes. The company has also scheduled the rights allotment for December 4.
Shares allotted under the issue are expected to be credited to investors' demat accounts on December 7 and listed on BSE on December 8. The disclosed timetable remains subject to the rights issue process and applicable approvals. The board or committee may extend the issue period, subject to the disclosed limit of 30 days from the opening date.
Why does the issue matter for shareholders and investors?
The rights issue offers eligible shareholders an opportunity to apply for additional Zodiac-JRD-MKJ shares at the announced issue price of ₹25. The 145:100 ratio is sizeable relative to the existing holding, making the decision to apply for, renounce, or allow entitlements to lapse relevant for shareholders before the closing date.
The company disclosed a pre-issue equity share capital of 1,09,75,625 shares. Assuming full subscription, the post-issue share count would rise to 2,69,75,625 shares. This larger equity base is a key factor for investors assessing the company's capital structure following completion of the issue.
A November 9 company announcement also referred to the acquisition of a 51.82% stake in Aerocom for ₹24.50 crore in the first tranche. The provided disclosures identify the transaction alongside the rights issue, while the final rights issue terms specify the maximum ₹40 crore fund raise. No share-price movement, financial-performance effect, or customer impact was disclosed in the available information.
What is the background to Zodiac-JRD-MKJ's capital raising?
Zodiac-JRD-MKJ has previously accessed shareholders through a rights issue. In 2025, it announced a rights issue at ₹40 per share in the ratio of 112 shares for every 100 shares held, with a record date of May 21, 2025.
The current issue has a lower offer price of ₹25 per share but a higher entitlement ratio of 145:100. The latest issue follows the August board authorisation and the November approval process, with BSE's in-principle approval preceding the final terms.
Conclusion
Zodiac-JRD-MKJ's proposed ₹40 crore rights issue gives eligible shareholders the right to apply for up to 1.60 crore new shares at ₹25 each from November 19 to December 3. Its 145:100 ratio, fully paid-up structure, and potential increase in the company's equity share count are the principal terms investors need to assess.
Investors should watch the November 30 deadline for on-market renunciation, the December 3 subscription close, and the scheduled December 4 allotment process. The next disclosed milestones are the expected credit of allotted shares on December 7 and their proposed BSE listing on December 8.


